Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) NOT-NS-20-107 Clinical Trial Not Allowed 05/16/2024 Brennan Streck, Ph.D., R.N., M.P.H.
Pancreatic Cancer Detection Consortium: Research Units PAR-21-334 (U01 Clinical Trial Optional) U01 Clinical Trial Optional 06/12/2024 Matthew Young, Ph.D.
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research NOT-CA-24-047 06/14/2024 Vignesh Gunasekharan, Ph.D.
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech NOT-NS-23-002 06/21/2024
Understanding Chronic Conditions Understudied Among Women RFA-OD-23-013 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 06/21/2024 Goli Samimi, Ph.D., M.P.H.
Understanding Chronic Conditions Understudied Among Women RFA-OD-23-014 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 06/21/2024 Goli Samimi, Ph.D., M.P.H.
Notice of Special Interest: Administrative Supplements to Support Collection of Spanish Normative Data and Determination of Test-Retest Reliability Estimates of Neuropsychological Tests for NCI Clinical Trials NOT-CA-24-040 06/22/2024 Cecilia Lee, Dr.P.H., R.N.
Consortium for Palliative Care Research Across the Lifespan RFA-AG-25-002 (U54 Clinical Trial Optional) U54 Clinical Trial Optional 07/03/2024 Brennan Streck, Ph.D., R.N., M.P.H.
Cancer Immunoprevention Network (CIP-Net) Research Projects RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed) UH3, UG3 07/04/2024 Altaf Mohammed, Ph.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-331 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2024 Edward Sauter, M.D., Ph.D.